Aspect Partners
PFE icon

Aspect Partners’s Pfizer PFE Stock Holding History

Aspect Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.1K Buy
669
+92
+16% +$2.45K 0.01% 202
2026
Q2 		$13.9K Sell
577
-29
-5% -$759 0.01% 236
2026
Q1 		$17K Sell
606
-221
-27% -$5.88K 0.01% 199
2025
Q4 		$20.6K Hold
827
– – 0.01% 191
2025
Q3 		$21.1K Sell
827
-979
-54% -$24.2K 0.01% 217
2025
Q2 		$43.8K Buy
1,806
+1,029
+132% +$24K 0.02% 156
2025
Q1 		$19.7K Hold
777
– – 0.01% 194
2024
Q4 		$20.6K Buy
777
+46
+6% +$1.25K 0.01% 196
2024
Q3 		$21.2K Hold
731
– – 0.01% 178
2024
Q2 		$20.5K Buy
731
+49
+7% +$1.35K 0.01% 182
2024
Q1 		$18.9K Buy
682
+75
+12% +$2.08K 0.01% 190
2023
Q4 		$17.5K Buy
+607
New +$18.3K 0.01% 190

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Aspect Partners's PFE Position: Q3 2026 in Review

Aspect Partners increased its Pfizer (PFE) stake by 16% in Q3 2026, buying an estimated $2.45K and bringing the position to 669 shares worth $19.1K. The position accounts for 0.01% of the portfolio, ranked #202.

Aspect Partners first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $43.8K in Q2 2025. 881 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Aspect Partners held 669 shares of Pfizer worth $19.1K as of Q3 2026.
  • Aspect Partners bought 92 Pfizer shares in Q3 2026, an estimated $2.45K.
  • Pfizer made up 0.01% of Aspect Partners's portfolio in Q3 2026, its #202 holding.
  • Aspect Partners first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
  • Aspect Partners's Pfizer position peaked at $43.8K in Q2 2025.
  • 881 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.